Career for Pharmacist in Indian Railways | Vacancies in North East Frontier Railway
ENGAGEMENT OF PARA-MEDICAL STAFF ON CONTRACT BASIS AGAINST VACANCIES EXISTING IN PARA - MEDICAL CATEGORY OF NORTHEAST FRONTIER RAILWAY, TINSUKIA & ITS DIVISIONS– THROUGH WALK-IN INTERVIEW.
It has been decided to conduct “WALK-IN-INTERVIEW" for filling up the following vacant posts of Para-Medical-Staff in this Railway by engaging suitable candidates, purely on contract basis. The engagement will be on a full time basis on fixed consolidated monthly remuneration for a period not exceeding 30-06-2018 (i.e the validity of the scheme) or appointment/availability of regularly selected candidates from Railway Recruitment Board/or availability of regular railway employee whichever is earlier Walk-in-interview will be conducted at Sub Divl. Hospital. New Tinsukia.
Post : Pharmacist III
Institute of Life Sciences (ILS) was established in the year 1989 as an autonomous institute under the administrative control of Govt. of Odisha. In 2002, it was taken over by the Department of Biotechnology, Govt. of India. The Prime Minister of India Shri Atal Bihari Vajpayee dedicated the institute to the nation in July 2003. Institute of Life Sciences has a broad vision of carrying out high-quality multidisciplinary research in the area of life sciences. The goal is for overall development and betterment of human health, longevity, agriculture and environment. The stated mission of the institution is to work towards upliftment of the human society and generate skilled human resources for future India. 
The National Institute of Immunology (NII) is an autonomous institution supported by the Department of Biotechnology, Government of India. The Institute is committed to advanced research addressing the basic mechanisms involved in body's defense, host-pathogen interactions and related areas with a view to contribute to the creation of an internationally competitive intellectual knowledge base as a sustainable source of innovative futuristic modalities of potential use in health care.
Thermo Fisher Scientific Inc is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $13 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.
Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme(Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees. Therefore, the requirement was felt of establishing a medicare system which could provide quality medicare to the retirees of the Armed Forces.
The Indian National Science Academy (INSA) was established in January 1935 with the object of promoting science in India and harnessing scientific knowledge for the cause of humanity and national welfare. The foundation of the Academy, earlier known as the National Institute of Sciences of India (NISI), was the outcome of joint endeavours of several organizations and individuals and the Indian Science Congress Association (ISCA) playing a leading role in this regard.
The Indian Institute of Technology Kanpur was established in the year 1960. The Parliament of India passed the ‘Institutes of Technology Act 1961’ declaring all the IITs as “Institutions of National Importance”. The Parliamentary Act has given absolute autonomy to the IITs. When the foundation stone of the IIT system was laid, it was perceived that taking help from the industrially advanced western countries might be lot more effective in achieving the status of a world class technical institute. Hence, IIT Kanpur had a massive collaboration with USA through a specially created programme- KIAP (Kanpur Indo American Programme).
Mahatma Gandhi Institute of Pharmacy (MGIP) was established in 2008. The Institute is approved by PCI, AICTE and affiliated to UPTU, Lucknow. It is offering Bachelor of Pharmacy (B.Pharm) and Master of Pharmacy (M.Pharm). MGIP is committed to provide world class education with specialized and experienced faculty members along with state-of-the-art facilities, including a modern practice lab that allows students to gain real-time experience in a functioning pharmacy.MGIP came into existence since 2008, is exclusively consecrated in the field of Pharmaceutical education & research and continuously generating pharmacy graduates and post graduates. It's also offering opportunities to contribute to the pharmaceutical industry right from licensed pharmacists to pharmaceutical scientists who develop the medications.
A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.
Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies and operates globally with approximately 50,000 employees. Since our founding in 1885, the company has remained family-owned and today we are committed to creating value through innovation in three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. Since we are privately held, we have the ability to take an innovative, long-term view. Our focus is on scientific discoveries and the introduction of truly novel medicines that improve lives and provide valuable services and support to patients and their families. Employees are challenged to take initiative and achieve outstanding results. Ultimately, our culture and drive allows us to maintain one of the highest levels of excellence in our industry.
Aries Pharmaceuticals, Inc. (Aries) is a wholly owned subsidiary of Aries Pharmaceuticals, Ltd., which is a wholly owned Subsidiary of Cosmo Pharmaceuticals, NV, a specialty pharmaceutical and medical device company focused on developing and commercializing best in class products in endoscopy and to treat gastrointestinal diseases. The Aries portfolio of four products, three of which are still in development, is licensed from Cosmo Pharmaceuticals N.V. to Aries Pharmaceuticals, Ltd.
